Judith Lalonde

Judith LaLonde currently serves as the Director of Regulatory Affairs at Larimar Therapeutics Inc. since May 2024, following a role as Director of Regulatory Affairs CMC at Novartis from January 2023 to May 2024. Previous positions include Director of CMC Regulatory Affairs at Gyroscope Therapeutics and Director of Regulatory Affairs at Carisma Therapeutics. Judith has extensive experience in regulatory affairs, particularly in formulating regulatory strategies and managing FDA submissions related to post-approval CMC changes. Judith's background includes significant roles at the University of Pennsylvania, where responsibilities included being Sr. Associate Director of Regulatory Affairs, and a foundational career at Teva Pharmaceuticals, GlaxoSmithKline, and as a post-doctoral researcher at Banaszak Lab. Judith holds a Ph.D. in Chemistry focusing on Protein Crystallography from the University of Pennsylvania, a Post Graduate Certificate in Regulatory Affairs from Temple University, and a BS in Chemistry from Syracuse University.